Argan: Expanding Margins And A $2.9 Billion Backlog Justify A Strong Buy

Argan is rated 'Strong Buy' as macro trends in AI and data center demand drive a robust $2.9B backlog, up from $1.4B YoY. AGX's revenue growth slowed to 12.7% YoY in Q4 2026, but I expect reacceleration as the backlog converts to revenue over the next 3+ years. Despite a 69x P/E, AGX's projected 32% revenue growth and margin expansion to 20%+ justify a fair market cap 34–88% above current levels.